PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
4.87%
Net income growth under 50% of CRWD's 27.14%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-29.88%
Both reduce yoy D&A, with CRWD at -0.30%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-520.85%
Negative yoy deferred tax while CRWD stands at 111.93%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
9.76%
SBC growth well above CRWD's 10.64%. Michael Burry would flag major dilution risk vs. competitor’s approach.
27.16%
Well above CRWD's 25.20% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
192.84%
AR growth well above CRWD's 98.75%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-17.79%
Negative yoy inventory while CRWD is 100.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-158.93%
Both negative yoy AP, with CRWD at -190.44%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-125.20%
Both reduce yoy usage, with CRWD at -24.32%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-139.22%
Negative yoy while CRWD is 2.95%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-5.81%
Negative yoy CFO while CRWD is 34.59%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
8.56%
Some CapEx rise while CRWD is negative at -79.46%. John Neff would see competitor possibly building capacity while we hold back expansions.
72.37%
Acquisition spending well above CRWD's 102.41%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
-1.91%
Both yoy lines negative, with CRWD at -465.00%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
110.06%
We have some liquidation growth while CRWD is negative at -88.12%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
24.43%
Less 'other investing' outflow yoy vs. CRWD's 85.74%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
67.81%
Investing outflow well above CRWD's 34.92%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
24.73%
We slightly raise equity while CRWD is negative at -88.02%. John Neff sees competitor possibly preserving share count or buying back shares.
36.36%
We have some buyback growth while CRWD is negative at -100.00%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.